BIND Therapeutics' Series B Round

BIND Therapeutics raised a round of funding on November 24, 2007.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its Medicinal Nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal Nano…

Articles about BIND Therapeutics' Series B Round: